Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 8, Issue , 2006, Pages

  Bultink, Irene E M ^a,b,c   Hamann, Dörte ^d   Seelen, Marc A ^e   Hart, Margreet H ^d   Dijkmans, Ben A C ^a,b,c   Daha, Mohamed R ^e   Voskuyl, Alexandre E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c JAN VAN BREEMEN INSTITUTE   (Netherlands)

^d SANQUIN RESEARCH   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MANNAN; MANNOSE BINDING LECTIN; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISONE; COMPLEMENT COMPONENT C4;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL INFECTION; GENITAL TRACT INFECTION; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; INFECTION; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MOUTH INFECTION; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REGRESSION ANALYSIS; SKIN INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPPER RESPIRATORY TRACT INFECTION; BACTERIAL INFECTIONS; BLOOD; DEFICIENCY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ADULT; BACTERIAL INFECTIONS; COMPLEMENT C4; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING LECTIN;

EID: 33846804076     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2095     Document Type: Article

References (37)

1. Gladman DD Hussain F Ibanez D Urowitz MB The nature and outcome of infection in systemic lupus erythematosus Lupus 2002 11 234-239 10.1191/ 0961203302lu170oa 12043887
2. Pryor BD Bologna SG Kahl LE Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus Arthritis Rheum 1996 39 1475-1482 8814058
3. Iliopoulos AG Tsokos GC Immunopathogenesis and spectrum of infections in systemic lupus erythematosus Semin Arthritis Rheum 1996 25 318-336 10.1016/S0049-0172(96)80018-7 8778988
4. Nossent JC Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients Semin Arthritis Rheum 1993 23 16-21 8235662
5. Reveille JD The molecular genetics of systemic lupus erythematosus and Sjogren's syndrome Curr Opin Rheumatol 1991 3 722-730 10.1097/ 00002281-199110000-00002 1751307
6. Nauta AJ Daha MR van Kooten C Roos A Recognition and clearance of apoptotic cells: A role for complement and pentraxins Trends Immunol 2003 24 148-154 10.1016/S1471-4906(03)00030-9 12615211
7. Davies EJ Snowden N Hillarby MC Carthy D Grennan DM Thomson W Ollier WE Mannose-binding protein gene polymorphism in systemic lupus erythematosus Arthritis Rheum 1995 38 110-114 7818559
8. Garred P Madsen HO Halberg P Petersen J Kronborg G Svejgaard A Andersen V Jacobsen S Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus Arthritis Rheum 1999 42 2145-2152 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-# 10524686
9. Garred P Voss A Madsen HO Junker P Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients Genes Immun 2001 2 442-450 10.1038/sj.gene.6363804 11781711
10. Takahashi R Tsutsumi A Ohtani K Muraki Y Goto D Matsumoto I Wakamiya N Sumida T Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus Ann Rheum Dis 2005 64 311-314 10.1136/ ard.2003.020172 15647440
11. Turner MW Mannose-binding lectin: The pluripotent molecule of the innate immune system Immunol Today 1996 17 532-540 10.1016/0167-5699(96)10062-1 8961631
12. Turner MW Hamvas RM Mannose-binding lectin: Structure, function, genetics and disease associations Rev Immunogenet 2000 2 305-322 11256742
13. Lee YH Witte T Momot T Schmidt RE Kaufman KM Harley JB Sestak AL The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: Two case-control studies and a meta-analysis Arthritis Rheum 2005 52 3966-3974 10.1002/art.21484 16320344
14. Summerfield JA Sumiya M Levin M Turner MW Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series BMJ 1997 314 1229-1232 9154025
15. Peterslund NA Koch C Jensenius JC Thiel S Association between deficiency of mannose-binding lectin and severe infections after chemotherapy Lancet 2001 358 637-638 10.1016/S0140-6736(01)05785-3 11530153
16. Crosdale DJ Ollier WE Thomson W Dyer PA Jensenious J Johnson RW Poulton KV Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids Eur J Immunogenet 2000 27 111-117 10.1046/ j.1365-2370.2000.00211.x 10940077
17. Garred P Larsen F Madsen HO Koch C Mannose-binding lectin deficiency - revisited Mol Immunol 2003 40 73-84 10.1016/S0161-5890(03)00104-4 12914814
18. Seelen MA van der Bijl EA Trouw LA Zuiverloon TC Munoz JR Fallaux-van den Houten FC Schlagwein N Daha MR Huizinga TW Roos A A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus Rheumatology (Oxford) 2005 44 111-119 10.1093/rheumatology/keh417 15479757
19. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1997 40 1725 9324032
20. Wolbink GJ Bollen J Baars JW ten Berge RJ Swaak AJ Paardekooper J Hack CE Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway J Immunol Methods 1993 163 67-76 10.1016/ 0022-1759(93)90240-8 7687639
21. Hoekzema R Martens M Brouwer MC Hack CE The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q Mol Immunol 1988 25 485-494 10.1016/0161-5890(88)90169-1 3261834
22. Kilpatrick DC Isolation of human mannan binding lectin, serum amyloid P component and related factors from Cohn fraction III Transfus Med 1997 7 289-294 10.1046/j.1365-3148.1997.d01-40.x 9510927
23. Roos A Bouwman LH Munoz J Zuiverloon T Faber-Krol MC Fallaux-van den Houten FC Klar-Mohamad N Hack CE Tilanus MG Daha MR Functional characterization of the lectin pathway of complement in human serum Mol Immunol 2003 39 655-668 10.1016/S0161-5890(02)00254-7 12493641
24. Hansen TK Thiel S Dall R Rosenfalck AM Trainer P Flyvbjerg A Jorgensen JO Christiansen JS GH strongly affects serum concentrations of mannan-binding lectin: Evidence for a new IGF-I independent immunomodulatory effect of GH J Clin Endocrinol Metab 2001 86 5383-5388 10.1210/jc.86.11.5383 11701711
25. Thiel S Holmskov U Hviid L Laursen SB Jensenius JC The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response Clin Exp Immunol 1992 90 31-35 1395098
26. Neth O Hann I Turner MW Klein NJ Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study Lancet 2001 358 614-618 10.1016/S0140-6736(01)05776-2 11530147
27. Zimmermann-Nielsen E Baatrup G Thorlacius-Ussing O Agnholt J Svehag SE Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE, Crohn's disease and colorectal cancer. Suppressed activation by SLE plasma Scand J Immunol 2002 55 105-110 10.1046/j.1365-3083.2002.01035.x 11841698
28. Vikingsson A Valdimarsson H Mannose-binding lectin deficiency and infections in homozygous and heterozygous patients with systemic lupus erythematosus: Comment on the article by Garred et al Arthritis Rheum 2000 43 1657-1658 10.1002/ 1529-0131(200007)43:7<1657::AID-ANR33>3.0.CO;2-G 10902774
29. Noel V Lortholary O Casassus P Cohen P Genereau T Andre MH Mouthon L Guillevin L Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus Ann Rheum Dis 2001 60 1141-1144 10.1136/ard.60.12.1141 11709457
30. Zonana-Nacach A Camargo-Coronel A Yanez P Sanchez L Jimenez-Balderas FJ Fraga A Infections in outpatients with systemic lupus erythematosus: A prospective study Lupus 2001 10 505-510 10.1191/096120301678416088 11480850
31. Kahl LE Herpes zoster infections in systemic lupus erythematosus: Risk factors and outcome J Rheumatol 1994 21 84-86 8151595
32. Petri M Genovese M Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins Lupus Cohort J Rheumatol 1992 19 1559-1565 1464868
33. Bruce IN Urowitz MB Gladman DD Ibanez D Steiner G Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study Arthritis Rheum 2003 48 3159-3167 10.1002/ art.11296 14613278
34. Selzer F Sutton-Tyrrell K Fitzgerald SG Pratt JE Tracy RP Kuller LH Manzi S Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus Arthritis Rheum 2004 50 151-159 10.1002/art.11418 14730611
35. Vitali C Bencivelli W Isenberg DA Smolen JS Snaith ML Sciuto M Neri R Bombardieri S Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clin Exp Rheumatol 1992 10 541-547 1458710
36. Bombardier C Gladman DD Urowitz MB Caron D Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 1992 35 630-640 1599520
37. Gladman D Ginzler E Goldsmith C Fortin P Liang M Urowitz M Bacon P Bombardieri S Hanly J Hay E The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus Arthritis Rheum 1996 39 363-369 8607884